HK Stock Market Move | BIODLINK-B (01875) resumes trading with a more than 58% opening increase, with WUXI XDC offering a cash tender offer at a premium of approximately 99%.
Dongyang Pharmaceutical-B (01875) opened significantly higher after resumption of trading, rising by 58.8% to HK$3.97 as of the time of writing, with a turnover of HK$1.1211 million.
After resumption of trading, BIODLINK-B (01875) opened significantly higher, up 58.8% to HKD 3.97 as of the time of writing, with a trading volume of HKD 1.1211 million.
On the news front, Dongyao Pharmaceutical and WUXI XDC (02268) jointly announced that WUXI XDC has proposed a voluntary offer to acquire all shares of Dongyao Pharmaceutical at a cash price of HKD 4 per share, representing a premium of approximately 99.00% over the closing price of HKD 2.01 per share before the trading halt. The maximum consideration of the offer is approximately HKD 2.79 billion. The offeror intends to maintain the listing of the shares on the Stock Exchange upon completion.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
